Pharmaceutical research facility certified green by GBI
Bristol-Myers Squibb Company's Wallingford, Conn., research facility was recently recognized by the Green Building Initiative (GBI) for assessing the energy-efficient and high-performance sustainability practices at the facility using a new module of the Green Globes rating system—Green Globes for Continual Improvement of Existing Buildings (Green Globes-CIEB). The building is the first in the U.S. to achieve a rating using the new Green Globes module. The R&D facility covers 180 acres and houses a five-story, one million-sf structure that was built in 1986 and accommodates about 1,250 employees. The design team at the S/L/A/M Collaborative's Boston office supported Bristol-Myers Squibb with its application, using the Green Globes tool to assess the performance of the building and identify areas for improvement. A GBI-authorized third-party building science expert was engaged to review construction documents for the renovation, conduct an on-site inspection, and confirm the original rating.